Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen

The invention relates to the use of quinolone and naphthyridon carboxylic acid derivatives, which are substituted by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl-radical in position seven, as well as to their pharmaceutically applicable hydrates and/or salts in the treatment of Helicobacter pylori infec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HIMMLER, THOMAS., 51519 ODENTHAL, DE, BARTEL, STEPHAN., 51465 BERGISCH GLADBACH, DE, SCHALLER, KLAUS, DR., 42109 WUPPERTAL, DE, WERLING, HANS-OTTO., 42113 WUPPERTAL, DE, JAETSCH, THOMAS., 50668 KOELN, DE, SCHENKE, THOMAS., 51469 BERGISCH GLADBACH, DE, MATZKE, MICHAEL., 42113 WUPPERTAL, DE, PETERSEN, UWE., 51375 LEVERKUSEN, DE, BAASNER, BERND., 51467 BERGISCH GLADBACH, DE, LABISCHINSKI, HARALD, DR., 14193 BERLIN, DE
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to the use of quinolone and naphthyridon carboxylic acid derivatives, which are substituted by a 2-oxa-5,8-diazabicyclo[4.3.0]-non-8-yl-radical in position seven, as well as to their pharmaceutically applicable hydrates and/or salts in the treatment of Helicobacter pylori infections and associated gastroduodenal diseases.